Symphogen is a clinical-stage antibody oncology focused company with a differentiated product pipeline and significant commercial opportunities.  Inspired by nature, led by science and driven by people, we passionately strive to make that discovery that may have great effect on the lives of patients, their families, and their caregivers. Based on our monoclonal antibody (mAb) research platform, we create differentiated mAb and mAb mixture products candidates. Our pre-clinical and clinical pipeline is well suited for a precision-medicine approach by addressing well-defined, biomarker-selected patient populations. We are headquartered in Denmark with operations in the US.

Biotechnology

Symphogen

Symphogen's headquarters in Ballerup, Denmark

People (46)

Jobs (0)

Other offices